{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MANAGEMENT OF REMIFENTANIL PATIENT CONTROLLED ANALGESIA FOR LABOUR"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "15019"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Anaesthetists, Midwives"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "nd22 October 2018"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "21st October 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Association of Anaesthetists of Great Britain and Ireland Obstetric Anaesthetists Association Guidelines for Obstetric Anaesthetic Services 2013"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "10,11"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's & Children's"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Sam Brayshaw, Anaesthetic Consultant"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "X MEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss A Rao, Lead Consultant for Obstetrics & Gynaecology"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "August 2018"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "3rd October 2018"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: October/ November 2018"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 9,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "AnitaRao/Alison Cuthbertson"
                    },
                    {
                        "text": "Clinical Director for Women's & Children"
                    },
                    {
                        "text": "August 2018"
                    },
                    {
                        "text": "Vidya Thakur"
                    },
                    {
                        "text": "Consultant for Obstetrics & Gynaecology"
                    },
                    {
                        "text": "Alison Cuthbertson"
                    },
                    {
                        "text": "Head of Midwifery/Nursing"
                    },
                    {
                        "text": "Amanda Dixon"
                    },
                    {
                        "text": "Lead Midwife for Acute In-Patient Services"
                    },
                    {
                        "text": "Chris Berner"
                    },
                    {
                        "text": "Lead Midwife for Clinical Governance"
                    },
                    {
                        "text": "Angela Woolfenden"
                    },
                    {
                        "text": "Lead Midwife for Community Services"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Specialist Midwife for Guidelines & Audit"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Pharmacy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Standard Infection Prevention 04072 Hand Hygiene 06036 Guideline for Maternity Record Keeping including Documentation in Handheld Records 09093 Epidural Analgesia in Maternity"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer/Comments:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Dr Robert Rudner, Dr Syed Qureshi, Dr Graham Philpot"
                    },
                    {
                        "text": "6th October 2015"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Sam Brayshaw"
                    },
                    {
                        "text": "22nd October 2018"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "INDEX"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "Appendix A - Remifentanil PCA Observation Chart Appendix B - Equality Impact Assessment (EIA)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "A choice and an alternative to an epidural analgesia for patients in labour should be offered where epidural service is contraindicated or in the case of patient's refusal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Safe and more effective alternative to conventional parenteral opiods (such as Morphine, Diamorphine or Pethidine) for labour should be offered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Remifentanil PCA (patient controlled anaesthesia) is a viable option not only for those who cannot have or don't want an epidural, but also for a third group, those who don't need an epidural but require just enough analgesia to allow them to cope with labour pain."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality and Diversity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid Essex Hospitals NHS Trust is committed to the provision of a service that is"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "text": "fair, accessible and meets the needs of all individuals. (Refer to Appendix 2)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Remifentanil is a potent synthetic opioid analgesic chemically related to fentanyl with unique pharmacokinetic profile. In theory, the rapid onset of analgesia (approximately 30\u201360 sec), which peaks at 1.2 min and ultra-short duration of action independent of duration of administration, liver and renal function offers substantial advantage or labor analgesia if the timing of dosing can be matched with uterine contractions. Due to its unique property, the timing of delivery of each Remifentanil dose for pain relief in labour is of crucial importance, and an IV bolus dose delivered at the beginning of a contraction (lasting on average 70 sec) is likely to provide analgesia for the following contraction. This can be achieved when Remifentanil is administered in PCA mode with PCA pump able to deliver a bolus in a very short period of time."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Remifentanil certainly crosses the placenta but appears to be rapidly metabolized and redistributed. There have been no reports of associated increases in neonatal respiratory depression or lower Apgar scores with the use of Remifentanil prior to delivery. This pharmacokinetic profile gives Remifentanil an advantage over the other opioids used for labour analgesia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "The main adverse effects observed in pregnant patients are nausea, vomiting, pruritus, sedation and respiratory depression."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "Remifentanil PCA for labour use is widespread but unlicensed; therefore must be prescribed by an anaesthetist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Indications"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Pain relief for labour where epidural analgesia is contraindicated e.g. coagulopathy, spinal surgery, spinal cord problems, local back skin infection, proven or possible sepsis or patient refusal. Such a patient will be usually seen in the anaesthetic antenatal clinic and there will be an anaesthetic plan in their notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Patient's request of Remifentanil PCA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "In general, any woman being offered Remifentanil PCA should be more than 36 weeks' gestation and be in established labour. If Remifentanil is being considered for use at a gestation of less than 36 weeks, a senior obstetrician must document in the clinical notes either the non-viable status of the fetus or specify the reason for requesting Remifentanil in that case."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Consultant anaesthetist has to be informed before starting Remifentanil PCA"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Contra-indications"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Inadequate midwifery staffing to provide 1:1 care"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Known sensitivity or allergy to remifentanil or other opioids"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Drug dependency"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Unestablished labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Recent opioid analgesia within 4 hours e.g. Morphine or Pethidine (Discuss with consultant anaesthetist if <4 hours)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Baseline SaOor cardiac disease (discuss with consultant anaesthetist prior to proposing a PCA)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Obstructive Sleep Apnoea"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "Fetal compromise - discuss with Obstetric and Neonatal teams"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 5.9,
                "text": "Inability to co-operate or operate the PCA pump"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Multiple pregnancies"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "prefix": 5.11,
                "text": "Severe pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 5.12,
                "text": "Intrauterine growth Retardation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 5.13,
                "text": "Preterm - Remifentanil should not be used at a gestation less than 36 weeks unless agreed by a consultant anaesthetist and obstetrician or the fetus is non-viable."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 5.14,
                "text": "Special Precautions:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "BMI >40"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "Diabetes (on insulin infusion)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Care a Patient with Remifentanil PCA for Labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "Patient education"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "6.1.1 An information leaflet should be provided and an opportunity for discussion given (Appendix 2)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "6.1.2 In particular the woman should be informed of the possible side-effects including drowsiness, pruritus, nausea, dizziness, bradycardia, respiratory depression and inadequate analgesia and documentation of this made in the notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "6.1.3 The patient must be shown how to use the PCA and should be told to press the button just before or at the start of a contraction i.e. when she first feels a \u2018tightening' not when the \u2018tightening' becomes painful."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "text": "NOTE: Only the patient can press the Remifentanil PCA demand button. The demand button must not be pressed by non-anaesthetic staff or the partner or relative."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "6.1.4 Nitrous Oxide (Entonox) may be safely used in addition to Remifentanil PCA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "6.1.5 Patient's consent should be obtained."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "Patient preparation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "6.2.1 Remifentanil PCA; requires a DEDICATED IV cannula (may be 22G),"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "6.2.2 Oxygen saturation (SaO) monitoring must be established before the woman starts using the PCA and must be monitored continuously while the remifentanil PCA is being used and for 15 minutes after discontinuation of the PCA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "6.2.5  Approximately one woman in ten using Remifentanil PCA will experience transient lowered oxygen saturation levels requiring the administration of additional oxygen via nasal specs or oxygen mask. The woman should be informed that oxygen might be used. Appropriate equipment must be available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Observations and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "The anaesthetist must be present for the first 15 min"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "Midwifery staffing to provide 1:1 care (constant presence of a midwife is mandatory)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Baseline BP, HR, SpO, RR, sedation score and pain score should be documented prior to starting Remifentanil PCA"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Continuous SpO and pulse rate monitoring must be used for the duration of the PCA and for 15 minutes after discontinuation of the PCA"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "A sedation score is to be recorded every  minutes (see sedation scale below)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Blood pressure measurements should be taken in the opposite arm to the PCA cannula to ensure unimpeded flow of remifentanil into the systemic circulation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Observations initially every 5 minutes for 20 min then every  minutes thereafter must be recorded on Remifentanil PCA Observation Chart for all women using Remifentanil PCA (Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "CTG monitoring is not required unless otherwise indicated"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "text": "NOTE: AVPU Sedation score:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 1,
                "text": "A - Fully Awake"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 1,
                "text": "V \u2013 Responds to Voice"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 1,
                "text": "P \u2013 Responds to Pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 1,
                "text": "U \u2013 Unrousable"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Equipment and Medication Preparation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Dedicated \u201cRemifentanil PCA for labour\u201d pump (CORE MEDICAL Sapphire Q)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Dedicated giving set (AP 403 CORE MEDICAL Sapphire Q)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Monitoring equipment to measure HR, SpO, BP and RR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "Equipment to Oxygen administration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 8.5,
                "text": "Presence of a bag-valve and mask and ability to deliver oxygen in the room"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 1,
                "text": "8.5.1 Preparation of Remifentanil and pump program"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "text": "8.5.2 Remifentanil solution must be prepared on the Labour Ward by the anaesthetist. Care must be taken with aseptic technique and careful labeling of the bag. 4mg (2 vials) of Remifentanil (Ultiva 2mg) are added to a 100 ml bag of 0.9% Sodium Chloride, resulting in a final solution concentration 40 micrograms per ml. Remifentanil solution is stable for 24 hours at room temperature after reconstitution."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "8.5.3 Dedicated remifentanil PCA pump set to deliver 1ml (40 mcg) bolus with a 3 min lockout period."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "8.5.4 If patient weighs less than 50 kg, 20 mcg bolus with a 2 min lockout period"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "ONLY AN ANAESTHETIST SHOULD PROGRAM THE PCA PUMP OR ADJUST VARIABLES"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "8.5.5 Remifentanil PCA for labour must be prescribed by the anaesthetist in the patient's drug chart. In addition anti-emetics and naloxon should be prescribed. Use of Remifentanil has to be recorded in the Controlled Drugs Book."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Complications Arising from Remifentanil PCA for Labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 1,
                "prefix": 9.1,
                "text": "Common adverse effects"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "9.1.1 Failure to provide adequate pain relief, with one in ten women requiring an epidural."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "9.1.2 Nausea, vomiting and itching often around the face (usually transient in nature due to the drug's short half life)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "9.1.3 Drowsiness and dizziness (often short lived)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "9.1.4 Respiratory depression (bradypnoea) with one in 10 women needing additional oxygen to breathe"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 28.0,
                "text": "9.1.5 Having to stop using remifentanil due to low oxygen levels or excessive sedation can occur in one in every  women"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "prefix": 9.2,
                "text": "Rare side effects"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "9.2.1  Apnoea or bradycardia requiring emergency resuscitation occurs in less than one in every 2200 women"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "In case of any significant problems online DATIX incident reporting form should be completed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Trouble Shooting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Analgesia not effective: Educate the mother to co-ordinate the bolus dose with the contraction. Entonox may be necessary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Nausea and Vomiting: Prescribe cyclizine 50mg IM/IV tds and consider Ondansetron 4mg IM/IV tds."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Pruritus: This is usually worst in the first two hours. If severe reduce the bolus dose of remifentanil or stop the PCA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Sedation: Excessive sedation is rare. If it occurs reduce the bolus dose or stop the PCA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Respiratory depression: Give oxygen supplementation (2-4 L/min via nasal specks). If respiratory depression is more profound, i.e. SaO is less than 92% despite supplemental oxygen, the PCA demand button should be temporarily removed from the patient, the patient encouraged to take deep breaths and the anaesthetist called to reduce the PCA dose. The bolus dose should be reduced by 10mcg and the patient observed with further reductions in the bolus dose if respiratory depression persists. Naloxone should be available and used in cases of severe respiratory depression."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "prefix": 10.6,
                "text": "If apnoea occurs: Stimulate patient and verbally encourage them to breathe. If this fails, call for urgent help, if necessary commence Basic Life Support, and get Cardiac Arrest Trolley."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "prefix": 10.7,
                "text": "Call anaesthetist and remove demand button from patient if adverse signs:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Points of Safety"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 1,
                "prefix": 11.1,
                "text": "Midwifery staffing to provide 1:1 care (constant presence of a midwife is mandatory)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Always use a dedicated cannula. PCA cannula is dedicated to administer Remifentanil only, and no other medications or fluids are allowed to be given."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Always flush the cannula with 5ml saline immediately after PCA is removed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "Only the mother is to use the PCA button. The PCA button must not be pressed by the midwifery staff or patient's relatives."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "The PCA can be used during delivery and or perineal repair."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "prefix": 11.6,
                "text": "Neonatal staff attendance at the birth is recommended. Although unlikely, neonatal respiratory depression is still possible. Naloxone must be available to administer to the baby if required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "All staff should follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "All staff should ensure that they follow Trust guidelines on infection prevention. All invasive devices must be inserted and cared for using High Impact Intervention guidelines to reduce the risk of infection and deliver safe care. This care should be recorded in the Saving Lives High Impact Intervention Monitoring Tool Paperwork (Medical Devices)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy and Policy, the Maternity annual audit work plan. The Audit Lead in liaison with the Risk Management Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "The findings of the audit will be reported to and approved by the Multi-disciplinary Risk Management Group (MRMG) and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "The audit report will be reported to the monthly Maternity Directorate Governance Meeting (MDGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Safety Group within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "Hill D: Remifentanil patient-controlled analgesia should be routinely available for use in labour. Int J Obstet Anesth 2008;17:336\u2013339."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "Hinova A, Fernando R: Remifentanil for labor analgesia. Anesthesia and Analgesia 2009; 109:1925-29."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "Freeman LM, Bloemenkamp KW, Franssen MT, et al: Remifentanil patient controlled analgesia versus epidural analgesia in labour. A multicentre randomized controlled trial. BMC Pregnancy Childbirth 2012; 12:63."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "Egan TD: Remifentanil pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet 1995; 29: 80-94."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "prefix": 35.0,
                "text": "Muchatula NA, Kinsella SM: Remifentanil for labour analgesia: time to draw breath? Anaesthesia 2013; 68: 227-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "Tveit TO, Halvorsen A, Seiler S and Rosland JH: Efficacy and side effects of intravenous remifentanil patient-controlled analgesia used in a stepwise approach for labour: an observational study. International Journal of Obstetric Anaesthesia,2013; 22: 19-25."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "Birnbach DJ, Ranasinghe JS: Is remifentanil a safe and effective alternative to neuraxial labor analgesia? It all depends. Anesthesia and Analgesia 2014;118/3:491- 493."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "Schnabel A, Hahn N, Broscheit J et al: Remifentanil for labour analgesia: a meta- analysis of randomised controlled trials. Eur J Anaesthesiol. 2012; 29(4):177-85."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "text": "Appendix A"
            }
        },
        {
            "type": "image",
            "sequence_num": 125,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.003.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "text": "REMIFENTANIL PCA FOR LABOUR - PRESCRIPTION AND OBSERVATION CHART"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 1,
                "text": "Hospital Number:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..  MATERNITY WARD"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 1,
                "text": "BROOMFIELD HOSPITAL DOB:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 1,
                "text": "DATE:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. Forenames:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 1,
                "text": "MIDWIFE Surname:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026  NAME:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 1,
                "text": "REMIFENTANIL SOLUTION: 4MG IN 100ML OF 0.9% SALINE (40 \u03bcg/ml) PCA pump settings:  INITIALLY:  ADJUSTED: INFUSION:  NO INFUSION"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 1,
                "text": "PCA BOLUS  1ML (40 \u03bcg)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "LOCK OUT PERIOD  2 MINUTES"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "text": "NAME  SIGNATURE  Date and Time"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "text": "Solution prepared by:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "text": "Checked by:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "text": "PCA pump set by:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "text": "PCA pump setting adjusted by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 139,
            "data": {
                "num_rows": 1,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Absolute Requirements"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "text": "The patient should have read the Remifentanil PCA patient information leaflet and given verbal consent."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 1,
                "text": "A midwife must at all times be in the room and provide one to one care (no exceptions)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "The Anaesthetist must be present on Labour Ward for the first 15 min of use."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "text": "Naloxone must be prescribed on the drug chart and available in the room for administration to\u2028 the mother. (Naloxone: 400 microgram add 3mL water for injection = 100mcg/mL)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "text": "A Paediatrician should be informed prior delivery and be told that the woman has had opioid drugs and a neonatal dose of Naloxone should be available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 1,
                "text": "Management Of Side Effects"
            }
        },
        {
            "type": "image",
            "sequence_num": 146,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.004.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Management of Remifentanil Patient Controlled Analgesia for Labour/15019/2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 1,
                "text": "ANY OF THESE OBSERVATIONS TRIGGER THE ACTION PLAN:"
            }
        },
        {
            "type": "image",
            "sequence_num": 150,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.005.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "Respiratory rate < 8"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "SaO"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 1,
                "text": "Sedation score > 3 (not responding to  verbal command)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 1,
                "text": "ACTION PLAN:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "Remove PCA trigger button from Patient"
            }
        },
        {
            "type": "image",
            "sequence_num": 156,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.006.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "Give or increase Oxygen"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "CALL ANAESTHETIST"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "Encourage patient to take deep breaths"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "Management of Remifentanil Patient Controlled Analgesia for Labour/15019/2.0"
            }
        },
        {
            "type": "image",
            "sequence_num": 161,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.007.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 1,
                "text": "Remifentanil PCA For Labour Observation Chart"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 1,
                "text": "SEDATION SCORE  PAIN SCORE"
            }
        },
        {
            "type": "image",
            "sequence_num": 164,
            "data": {
                "url": "15019 Remifentanil Patient Controlled Analgesia for Labour 2.0.009.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 1,
                "text": "A \u2013 Fully Awake  0 \u2013 No Pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 1,
                "text": "V \u2013 Responds to Voice  1 \u2013 Mild Pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 1,
                "text": "P \u2013 Responds to Pain  2 \u2013 Moderate Pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 1,
                "text": "U - Unresponsive  3 \u2013 Severe Pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "text": "4 \u2013 Excruciating Pain"
            }
        },
        {
            "type": "table",
            "sequence_num": 170,
            "data": {
                "num_rows": 11,
                "num_cols": 17,
                "table_items": [
                    {
                        "text": "Measure SpO2 continuously other observations every 30 minutes (every 5 minutes for the first 20 minutes or if any concerns)"
                    },
                    {
                        "text": "Time"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "SaO2 %"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Respiratory rate"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "O2/Entonox"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Heart Rate"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Blood Pressure"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sedation Score"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Pain Score"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Initials"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Continue observations for  minutes after the PCA has been stopped"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "text": "Management of Remifentanil Patient Controlled Analgesia for Labour/15019/2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 1,
                "text": "Appendix B"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 1,
                "text": "Equality Impact Assessment (EIA)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "Title of document being impact-assessed:"
            }
        },
        {
            "type": "table",
            "sequence_num": 177,
            "data": {
                "num_rows": 10,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Equality or human rights concern (see guidance notes below)"
                    },
                    {
                        "text": "Does this item have any differential impact on the equality groups listed? Brief description of impact."
                    },
                    {
                        "text": "How is this impact being addressed?"
                    },
                    {
                        "text": "Gender"
                    },
                    {
                        "text": "This is only available to women in labour"
                    },
                    {
                        "text": "N/A"
                    },
                    {
                        "text": "Race and ethnicity"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Disability"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Religion, faith and belief"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sexual orientation"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Age"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Transgender people"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Social class"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Carers ."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "text": "Date of assessment: 04/09/2018 Names of Assessor(s): S. Brayshaw"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Page  of"
            }
        }
    ]
}